One Dose of Psilocybin Changes the Human Brain
A large team of scientists, found that a single dose of psilocybin created positive changes in the brain and well-being, one hour and one month after administration.
University of California San Francisco
Give to UCSF
Displaying 1 - 30 of 930
-
-
HD Probes Show for the First Time How Epileptic ‘Brain Blips’ Occur
Epilepsy physicians Jon Kleen and Eddie Chang used high-resolution technology to see how cognition is disrupted in people with epilepsy and predict when it will occur. The new view points the way to being able to fend of these disruptions.
-
New Study Asks, Can Probiotics Help Reduce Depression in Teens?
UCSF's Cherry Leung, associate professor of community health systems with the UC San Francisco School of Nursing, researches the gut-brain axis as a potential adjunct therapy for improving adolescent mental health.
-
“Love Island-Style” Power Couple Might Help Unlock HER2 Cancer
Ten UCSF graduate students presented their research in accessible, 3-minute talks at the 2026 Grad Slam event. This year’s first-place talk was by Brandon Corteau on how HER2 and HER3 can become a toxic power couple when paired together, and lead to the development of breast cancer.
-
Scientists Discover How Multiple Sclerosis Kills Neurons
Researchers discover that the nerve cells that make us uniquely human are also uniquely vulnerable to dying during the waves of inflammation that occur in multiple sclerosis.
-
UCSF Scientists Are Working To Detect the Earliest Signs of Schizophrenia — And Prevent It
-
Stop Schizophrenia Before It Starts? We Might Be on The Right Track
UCSF researcher Daniel Mathalon, MD, PhD, believes that burgeoning knowledge about biomarkers — biological measures of a medical condition that also serve as markers of treatment effectiveness — could help intercept schizophrenia.
-
Are Tau PET Scans “Lighting Up” Too Much of the Brain?
Tau proteins play an important role in our normal brain function, mainly by helping to stabilize neurons in the brain. But in Alzheimer’s disease, tau proteins can misfold and tangle inside neurons.
-
Decoding Parkinson’s Patients’ Movements in the Real World
For years, scientists have studied how the brain controls movement by asking patients to perform structured tasks while connected to multiple sensors in a lab. While these studies have provided
-
Immune Cells Linked to Epstein-Barr Virus May Play a Role in MS
A study from UCSF shows a previously unknown connection between the Epstein-Barr virus, known to play a role in MS, and an understudied type of immune cell.
-
Awake to Protect Speech During Brain Surgery
-
This Cellular Hazmat Team Cleans Up Tau. Can It Prevent Dementia?
Researchers found a "garbage man" enzyme that tags toxic clumps of proteins in the brain for removal, and saw a correlation with resilience against dementia.
-
Improving Future Alzheimer’s Treatment by Guiding Today’s Breakthroughs
In the last few years, progress has been made in the fight against Alzheimer’s disease with a class of therapies called anti-amyloid antibodies (anti-Aβ). These monoclonal anti-Aβs are proteins made
-
Your Pain Meds’ Side Effects May Be Masquerading as Heart Failure
Matthew Growdon's study finds "prescription cascades" where drug side effects lead to unnecessary second prescriptions, causing further harm and costly hospitalizations.
-
Why a Foreign Language Sounds Like a Blur to Non-Native Ears
Scientists have thought that when we hear language, the brain processes it the same way, whether it's familiar or foreign. A new study reveals that exposure to a language changes how certain clusters of neurons respond to the familiar sounds. From those changes, we develop the understanding of syllables, words, and syntax.
-
This New Tech Helps Parkinson’s Patients Who Have Trouble Walking
UCSF researchers used AI to personalize Deep Brain Stimulation (DBS) for Parkinson's gait problems, leading to meaningful, customized improvements in walking and mobility—a major breakthrough for patients.
-
Why Is It So Hard to Adjust When Clocks ‘Fall Back’?
Neurologist Dr. Ptacek explains how "falling back" disrupts the 24-hour circadian clock, affecting mood and performance, with mitigation tips.
-
How to Turn Genes On or Off to Protect Brain Cells From Dementia
Martin Kampmann’s work, supported by the National Institutes of Health (NIH), maps cellular “decision points” that determine whether brain cells survive or die, laying the groundwork for treatments that intervene before irreversible brain damage occurs from dementia.
-
How Multiple Sclerosis Harms a Brain Long Before Symptoms Appear
Image In the human brain, neurofilament light chain (NfL, shown in brown) is seen in brain cells and the neural wires that connect them. UCSF
-
Could This Birth Control Shot Increase Your Risk for Brain Tumor?
UCSF radiation oncologist David Raleigh, MD, PhD, studies the link between brain tumors and injectable birth control.
-
Scientists Used AI to Map Uncharted Areas of the Mouse Brain
-
Signs of Dyslexia and Reading Troubles Can Be Spotted in Kindergarten — or Even Preschool
-
Could This Novel Therapy Calm Anxiety for Millions of Americans?
Generalized anxiety disorder affects 1 in 20 U.S. adults. Those with serious symptoms may isolate themselves to the point that they rarely leave their home.
-
UCSF Study on CTE Seeks Living Athletes’ Data to Help Diagnose the Degenerative Disease
-
If Anti-Seizure Meds Don’t Work for Epilepsy, Can Surgery Help?
Vikram Rao, director of the UCSF Epilepsy Center, discusses why a third of seizure patients don’t respond to medication and the promising new surgical and technological treatments available.
-
These Cells Have Hidden Powers That Could Heal Brain Injuries
UCSF scientists discovered that an overlooked cell type in the brain plays a central role in healing traumatic brain injury. Understanding how it does this will lead to treatments for injuries that currently have only minimal interventions.
-
Scientists Look to Commercial Dyes to Help them Diagnose Dementia
A study screened dyes found in textiles and in the laser industry that can be used in imaging for preclinical studies to diagnose and differentiate between neurodegenerative diseases. Currently, dyes used in mouse studies cannot distinguish between different types of dementia.
-
Bruce Willis’ Personality Changes Key to Dementia Diagnosis: UCSF Expert
-
From Chronic Pain to Parkinson’s, 4 Ways DBS is Changing Care
UCSF looks back on four ways it pioneered deep brain stimulation with the help of federal funding, helping patients with Parkinson’s Disease, chronic pain, depression, and more.
-
This Protein Slows the Aging Brain, and We Know How to Counter It
Scientists discover a protein that gets concentrated in the brain during aging, leading brain connections to wither and cognitive decline to accelerate - and a way to counter its effects.
